ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q4 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,343,000 | -34.6% | 7,807 | -52.3% | 0.01% | -36.4% |
| Q2 2021 | $2,054,000 | +82.4% | 16,368 | +97.2% | 0.02% | +57.1% |
| Q1 2021 | $1,126,000 | +72.4% | 8,300 | +62.7% | 0.01% | +55.6% |
| Q4 2020 | $653,000 | -68.1% | 5,100 | -76.2% | 0.01% | -66.7% |
| Q2 2020 | $2,044,000 | +34.7% | 21,452 | -25.0% | 0.03% | -27.0% |
| Q4 2019 | $1,517,000 | +36.2% | 28,611 | +1.5% | 0.04% | +12.1% |
| Q3 2019 | $1,114,000 | -79.3% | 28,200 | -80.4% | 0.03% | -93.3% |
| Q3 2017 | $5,375,000 | +2050.0% | 144,017 | +1429.0% | 0.49% | +1864.0% |
| Q1 2017 | $250,000 | – | 9,419 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |